Year-over-year articles
AGIANA PHARMACEUTICALS AS
5 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 927 648 946
Grew 65% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2025 with 2024 for AGIANA PHARMACEUTICALS AS. Revenue 534.6k NOK → 881.5k NOK (+64.9%). Net result -4.50m NOK → -15.17m NOK. Equity…
Grew 127% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2024 with 2023 for AGIANA PHARMACEUTICALS AS. Revenue 235.3k NOK → 534.6k NOK (+127.2%). Net result -2.95m NOK → -4.50m NOK. Equity…
Weaker earnings, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for AGIANA PHARMACEUTICALS AS. Revenue 0 NOK → 235.3k NOK. Net result -2 958 NOK → -2.95m NOK. Equity -2.93m NOK →…
Slipped into loss
Comparing Årsregnskap 2022 with 2021 for AGIANA PHARMACEUTICALS AS. Revenue 0 NOK → 0 NOK (0.0%). Net result 0 NOK → -2 958 NOK. Equity 30.0k NOK → -2.93m NOK.
First published accounts
First year in the published series for AGIANA PHARMACEUTICALS AS (2021). No prior-year comparative in this dataset.